New Pancreatic Cancer Treatment Wipes Out Tumors and Blocks Drug Resistance

From SciTechDaily

Existing treatments for pancreatic cancer often stop working within a few months because tumors quickly develop resistance to the drugs. Researchers at Spain’s National Cancer Research Centre (CNIO) report that they have prevented this resistance in animal studies by using a three-drug combination therapy.

The researchers say their findings “pave the way for the design of combined therapies that may improve survival,” although they caution that this progress will not immediately translate into new treatments for patients. Mariano Barbacid, head of the Experimental Oncology Group at CNIO, emphasizes that “we are not yet in a position to carry out clinical trials with this triple therapy.”